XenoGesis supported TropIQ’s research into vector-borne disease control

XenoGesis supported TropIQ’s research into vector-borne disease control
July 11, 2018 suecarr

XenoGesis worked with TropIQ to support their research project into oral insecticides for vector-borne disease control, the findings of which have been published in the PNAS Journal.

The research shows that, when given to humans, insect killing veterinarian drugs could greatly reduce the local population of insect-vectors and therefore the transmission of diseases such as malaria, Zika, dengue and Leishmaniasis.

XenoGesis provided the data on the prediction of human pharmacokinetics of two compounds – afoxolaner and fluralaner.  TropIQ worked on the computational modelling which showed that the seasonal mass administration of a single dose of these drugs to a fraction of a regional population could dramatically reduce Zika and malaria clinical cases in high risk geographic areas.

Read the full journal article here.